
Cancer Informatics, Journal Year: 2025, Volume and Issue: 24
Published: Jan. 1, 2025
Hepatitis B virus (HBV) causes liver cancer, which is the third most common cause of cancer-related death worldwide. Chronic inflammation via HBV in host hepatocytes hepatocyte remodeling (hepatocyte transformation and immortalization) hepatocellular carcinoma (HCC). Recognizing cancer stages accurately to optimize early screening diagnosis a primary concern outlook HBV-induced cancer. Genomic signatures play important roles addressing this issue. Recently, machine learning (ML) models bioinformatics analysis have become very discovering novel genomic for diagnosis, treatment, prognosis hepatic cell HCC. We discuss recent literature on ML approach revealed diagnosing forecasting HBV-associated Various signatures, including various microRNAs their associated genes, long noncoding RNAs (lncRNAs), small nucleolar (snoRNAs), been discovered be involved upregulation downregulation HBV-HCC. Moreover, these genetic biomarkers also affect different biological processes, such as proliferation, migration, circulation, assault, dissemination, antiapoptosis, mitogenesis, transformation, angiogenesis HBV-infected hepatocytes.
Language: Английский